Inferra AI / Company / ACHC
Acadia Healthcare Company, Inc.
ACHC · Health Care
Last earnings Jul 28, 2026
Key results
Revenuequarter
9.5%
revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Revenue for the second quarter increased 9.2% over the second quarter last year, and Adjusted EBITDA improved 7.6% over the prior-year period.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
AI analysis
Q2 2025 · reported Aug 5, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance · company-stated
“attributable to Acadia totaled $30.1 million”
“increased 7.6%”
Guidance stated in the release's Business Outlook table for 2025; no direction stated — figures as stated in the table.
Capital allocation
As of June 30, 2025, the Company had $131.4 million in cash and cash equivalents and $828.3 million available under its $1.0 billion revolving credit facility.
During the second quarter of 2025, the Company repurchased 103,939 shares for a total of $3.2 million, bringing total year-to-date repurchases to 1,706,625 shares for a total of $50.4 million.
Event summary
A reconciliation of all non-GAAP financial measures in this press release begins on page 9
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Revenue: “Revenue totaled $869.2 million”
Net income: “Net income attributable to Acadia totaled $30.1 million”
Adjusted EBITDA: “Adjusted EBITDA increased 7.6%”
Revenue (“2025”)
“Revenue totaled $869.2 million”
Net income (“2025”)
“Net income attributable to Acadia totaled $30.1 million”
Adjusted EBITDA (“2025”)
“Adjusted EBITDA increased 7.6%”
Guidance stated in the release's Business Outlook table for 2025; no direction stated — figures as stated in the table.
Capital allocation
As of June 30, 2025, the Company had $131.4 million in cash and cash equivalents and $828.3 million available under its $1.0 billion revolving credit facility.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
During the second quarter of 2025, the Company repurchased 103,939 shares for a total of $3.2 million, bringing total year-to-date repurchases to 1,706,625 shares for a total of $50.4 million.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
- MORE - ACHC Reports Second Quarter 2025 Results Page 4 August 5, 2025 Forward-Looking Information This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act ), including statements related to our strategy, growth, anticipated operating results for future periods and our share repurchase program.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Share Repurchase Authorization Disclaimer Acadia s share repurchase program permits the Company to make repurchases on a discretionary basis as determined by management, subject to market conditions, applicable legal requirements, available liquidity, compliance with the Company's debt agreements, and other appropriate factors.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Repurchases under the share repurchase program are to be made through open market or privately negotiated transactions and may be made pursuant to plans entered into in accordance with Rule 10b5-1 and/or Rule 10b-18 of the Exchange Act.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
The share repurchase program does not have a termination date, does not obligate Acadia to acquire any particular amount of common stock, and may be modified, extended, suspended, or discontinued by the Company s Board of Directors at any time without prior notice.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Strategy & priorities
Second Quarter Results Chris Hunter, Chief Executive Officer of Acadia, remarked, Our results for the second quarter of 2025 reflect solid execution of our growth strategy as we continued to address the critical demand for behavioral health services in the United States.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
With our proven operating model and strong focus on clinical quality, Acadia is uniquely positioned across the care continuum to fill a critical gap for evidence-based specialized behavioral health services.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
As we continue to expand our market reach, we also remain focused on strengthening our capabilities and leveraging technology to drive greater efficiencies in care delivery and deliver favorable clinical outcomes.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
- MORE - ACHC Reports Second Quarter 2025 Results Page 2 August 5, 2025 Strategic Investments for Long-Term Growth During the second quarter of 2025, the Company continued to make progress in meeting its strategic growth objectives, adding 101 beds to existing facilities, bringing the total to 191 beds added to existing facilities for the first half of 2025.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Cash and Liquidity Acadia has continued to maintain a strong financial position with sufficient capital to make strategic investments in its business.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Risks & headwinds
Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Government investigations include legal fees and settlement costs related to certain litigation.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
(d) Represents legal settlements expense related to costs associated with the Desert Hills litigation.
SEC original ↗Acadia Healthcare Company, Inc. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Legal Proceedings 34 Item 1A.
SEC original ↗Acadia Healthcare Company, Inc. — 10-Q Quarterly report10-QJul 28, 2026
However, it is unlikely a significant reversal of revenue will occur when the uncertainty is resolved, and therefore, the Company has included the variable consideration in the estimated transaction price.
SEC original ↗Acadia Healthcare Company, Inc. — 10-Q Quarterly report10-QJul 28, 2026
Commitments and Contingencies Professional and General Liability The Company is subject to medical malpractice and other lawsuits due to the nature of the services the Company provides.
SEC original ↗Acadia Healthcare Company, Inc. — 10-Q Quarterly report10-QJul 28, 2026
Earnings deck slides
0 decks with slide viewAcadia Healthcare Company, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Acadia Healthcare Company, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
33 documentsEarnings releases
13 documentsPresentations
2 documents
Transcripts
0 documentsNo transcripts for Acadia Healthcare Company, Inc. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.